Liposomal Doxorubicin Market is Expected to Reach US$ 2,367.5 Million by 2034, Rising at a 6.3% CAGR | Future Market Insights Inc. NEWARK, Del, July 03, 2024 (GLOBE NEWSWIRE) -- The liposomal doxorubicin market is estimated to be worth USD 1,281.3 Million in 2024 and is projected to be valued at USD 2,367.5 Million in 2034....

Liposome Drug Delivery Market Size Worth $6,992.95 Million, Globally, by 2027 at 8.8% CAGR - Exclusive Report by The Insight Partners New York, Dec. 16, 2021 (GLOBE NEWSWIRE) -- According to the new market research report "Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Liposomal...